Supernus Pharmaceuticals (SUPN) Change in Account Payables (2014 - 2020)
Supernus Pharmaceuticals (SUPN) posted quarterly Change in Account Payables of $5.7 million for Q3 2020, up 564.92% year-over-year from $853037.5 in Q4 2019, and up 180.83% on a QoQ basis from -$7.0 million in Q1 2020.
Supernus Pharmaceuticals (SUPN) Change in Account Payables (2014 - 2020) Analysis & Trends
Supernus Pharmaceuticals has reported Change in Account Payables for 7 years, with the latest figure at $5.7 million in Q3 2020.
- Change in Account Payables for Q3 2020 came in at $5.7 million, up 564.92% year-over-year; the trailing twelve-month figure through Sep 2020 was $4.7 million (up 167.8% YoY), and the FY2019 annual result was $7.0 million, up 294.58% from the prior year.
- Change in Account Payables advanced to $5.7 million in Q3 2020, from -$7.0 million in the prior quarter.
- Over five years, Change in Account Payables peaked at $7.3 million in Q4 2019 and troughed at -$7.0 million in Q1 2020.
- A 5-year average of $271611.1 and a median of -$389000.0 in 2016 frame the typical range for Change in Account Payables.
- The widest annual swing landed in 2017, when Change in Account Payables jumped 937.63%; it then plunged 1060.12% in 2018.
- A 5-year view of Change in Account Payables shows it stood at $5.1 million in 2016, then sank by 86.43% to $692000.0 in 2017, then plunged by 1060.12% to -$6.6 million in 2018, then soared by 209.81% to $7.3 million in 2019, then retreated by 22.26% to $5.7 million in 2020.
- Per Business Quant data, the three most recent Change in Account Payables figures were $5.7 million in Q3 2020, -$7.0 million in Q1 2020, and $7.3 million in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -53.00 Mn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -143.74 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -21.20 Mn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Supernus Pharmaceuticals | 2.74 Bn | 2.37 Bn | 185.39 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 5.67 Mn |
| Sep 30, 2020 | 5.67 Mn |
| Mar 31, 2020 | -7.02 Mn |
| Mar 31, 2020 | -7.02 Mn |
| Dec 31, 2019 | 7.30 Mn |
| Dec 31, 2019 | 7.30 Mn |
| Sep 30, 2019 | -1.22 Mn |
| Sep 30, 2019 | -1.22 Mn |
| Jun 30, 2019 | -3.16 Mn |
| Jun 30, 2019 | -3.16 Mn |
| Mar 31, 2019 | 4.05 Mn |
| Mar 31, 2019 | 4.05 Mn |
| Dec 31, 2018 | -6.64 Mn |
| Dec 31, 2018 | -6.64 Mn |
| Sep 30, 2018 | 6.90 Mn |
| Sep 30, 2018 | 6.90 Mn |
| Jun 30, 2018 | -398,000.00 |
| Jun 30, 2018 | -398,000.00 |
| Mar 31, 2018 | -3.44 Mn |
| Mar 31, 2018 | -3.44 Mn |